News
                1 - 2 of 2 news items 
             
              
- 
            
Danish Medicines Agency investigates a case of inflammatory condition reported after COVID-19 vaccination| 26 August 2021 |In collaboration with the EMA, the Danish Medicines Agency is investigating whether the rare inflammatory condition of MIS-C, previously observed as an aftereffect of COVID-19 infection in children and adolescents, can also occur after vaccination. While no causality with the vaccine has been established, it cannot be excluded either. 
- 
            
Error in company names and marketing status at www.indlaegsseddel.dk| 10 August 2021 |The Danish Medicines Agency is aware that an incorrect company name and marketing status are shown for some medicines at www.indlaegsseddel.dk. 
